Form 4: Imunon Executive Chairman Acquires 100,000 Stock Options

Michael H. Tardugno, Executive Chairman of Imunon, Inc., acquired 100,000 stock options at an exercise price of $1.22 on June 12, 2024.

Summary

• On June 12, 2024, Michael H. Tardugno, the Executive Chairman of the Board of Imunon, Inc., acquired 100,000 stock options.
• The exercise price for these options is $1.22 per share.
• The options vest in three tranches: 1/2 on the grant date, 1/4 on the one-year anniversary, and 1/4 on the two-year anniversary of the grant date.
• The options expire on June 12, 2034.
• Following the transaction, Mr. Tardugno directly owns 328,346 shares of Imunon's common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by a key executive can be interpreted as a sign of confidence, but it's a routine transaction.

Positives

• The acquisition of stock options by the Executive Chairman could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence by the Executive Chairman.

Key Dates

Keywords

Imunon, Stock Options, Form 4, Executive Chairman, Michael Tardugno, Beneficial Ownership, IMNN